Acute pulmonary exacerbations of sarcoidosis

Chest

Volumn 142, Issue 4, 2012, Pages 827-836

  Panselinas, Efstratios ^a   Judson, Marc A ^b  

^a 411 General Army Hospital   (Greece)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CHLOROQUINE; COLESTYRAMINE; CORTICOSTEROID; ETANERCEPT; FOLIC ACID; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; PENTOXIFYLLINE; PREDNISONE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ALOPECIA; BLOATING; BONE MARROW SUPPRESSION; CATARACT; CENTRAL DEMYELINATING DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DEMYELINATING DISEASE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DIZZINESS; DRUG DOSE REDUCTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; FATIGUE; HEALTH CARE QUALITY; HUMAN; LEUKOPENIA; LOW DRUG DOSE; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; MYALGIA; NAUSEA; NEUROPATHY; NOTE; OSTEOPOROSIS; PATHOGENESIS; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RETINA INJURY; RISK FACTOR; SARCOIDOSIS; SEDATION; SIDE EFFECT; STOMATITIS; TOXIC HEPATITIS; TUBERCULOSIS; WEIGHT GAIN;

EID: 84867134596     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1060     Document Type: Note

References (77)

1. Mañá J, Montero A, Vidal M, Marcoval J, Pujol R. Recurrent sarcoidosis: a study of 17 patients with 24 episodes of recurrence. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20(3):212-221. (Pubitemid 37351543)
2. Rizzato G, Montemurro L, Colombo P. The late follow-up of chronic sarcoid patients previously treated with corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis. 1998;15(1):52-58. (Pubitemid 28174897)
3. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest. 1997;111(3):623-631. (Pubitemid 27132936)
4. Hunninghake GW, Gilbert S, Pueringer R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med. 1994;149(4 Pt 1):893-898. (Pubitemid 24108477)
5. McKinzie BP, Bullington WM, Mazur JE, Judson MA. Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. Am J Med Sci. 2010;339(1):1-4.
6. Judson MA, Gilbert GE, Rodgers JK, Greer CF, Schabel SI. The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis. Respirology. 2008;13(1):97-102.
7. Johns CJ, Schonfeld SA, Scott PP, Zachary JB, MacGregor MI. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications. Ann N Y Acad Sci. 1986;465:702-712. (Pubitemid 16006612)
8. Israel HL, Karlin P, Menduke H, DeLisser OG. Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions. Ann N Y Acad Sci. 1986;465:609-618. (Pubitemid 16006600)
9. Rodrigues SC, Rocha NA, Lima MS, et al. Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28(1):34-43.
10. Eule H, Weinecke A, Roth I, Wuthe H. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study. Ann N Y Acad Sci. 1986;465:695-701. (Pubitemid 16006611)
11. Izumi T. Sarcoidosis in Kyoto (1963-1986). Sarcoidosis. 1988;5(2):142-146.
12. Alazemi S, Campos MA. Interferon-induced sarcoidosis. Int J Clin Pract. 2006;60(2):201-211. (Pubitemid 43740500)
13. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol. 2005;141(7):865-868. (Pubitemid 41058068)
14. Li SD, Yong S, Srinivas D, Van Thiel DH. Reactivation of sarcoidosis during interferon therapy. J Gastroenterol. 2002;37(1):50-54. (Pubitemid 34144963)
15. Lenner R, Bregman Z, Teirstein AS, DePalo L. Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy. Chest. 2001;119(3):978-981. (Pubitemid 32197681)
16. Mirmirani P, Maurer TA, Herndier B, McGrath M, Weinstein MD, Berger TG. Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome. J Am Acad Dermatol. 1999;41(2 pt 2):285-286. (Pubitemid 29381995)
17. Morris DG, Jasmer RM, Huang L, Gotway MB, Nishimura S, King TE Jr. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest. 2003;124(3):929-935. (Pubitemid 37123311)
18. Walker S, Mikhail G, Banner N, et al. Medium term results of lung transplantation for end stage pulmonary sarcoidosis. Thorax. 1998;53(4):281-284. (Pubitemid 28215788)
19. Barbers RG. Role of transplantation (lung, liver, and heart) in sarcoidosis. Clin Chest Med. 1997;18(4):865-874. (Pubitemid 27525447)
20. Nunley DR, Hattler B, Keenan RJ, et al. Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(1):93-100. (Pubitemid 29164276)
21. Johnson BA, Duncan SR, Ohori NP, et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis. 1993;148(5):1373-1377. (Pubitemid 23326041)
22. Martinez FJ, Orens JB, Deeb M, Brunsting LA, Flint A, Lynch JP III. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest. 1994;106(5):1597-1599. (Pubitemid 24346137)
23. Padilla ML, Schilero GJ, Teirstein AS. Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14(1):16-22. (Pubitemid 27170551)
24. Kazerooni EA, Cascade PN. Recurrent miliary sarcoidosis after lung transplantation. Radiology. 1995;194(3):913.
25. Carré P, Rouquette I, Durand D, et al. Recurrence of sarcoidosis in a human lung allograft. Transplant Proc. 1995;27(2):1686.
26. Müller C, Briegel J, Haller M, et al. Sarcoidosis recurrence following lung transplantation. Transplantation. 1996;61(7):1117-1119. (Pubitemid 126426026)
27. Kazerooni EA, Jackson C, Cascade PN. Sarcoidosis: recurrence of primary disease in transplanted lungs. Radiology. 1994;192(2):461-464. (Pubitemid 24233927)
28. Collins J, Hartman MJ, Warner TF, et al. Frequency and CT findings of recurrent disease after lung transplantation. Radiology. 2001;219(2):503-509. (Pubitemid 32336369)
29. Bjørtuft O, Foerster A, Boe J, Geiran O. Single lung transplantation as treatment for end-stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient. J Heart Lung Transplant. 1994;13(1 pt 1):24-29. (Pubitemid 24068934)
30. Louie GH, Chitkara P, Ward MM. Relapse of sarcoidosis upon treatment with etanercept. Ann Rheum Dis. 2008;67(6):896-898. (Pubitemid 351829400)
31. van der Stoep D, Braunstahl GJ, van Zeben J, Wouters J. Sarcoidosis during anti-tumor necrosis factor-alpha ther apy: no relapse after rechallenge. J Rheumatol. 2009;36(12):2847-2848.
32. Burns AM, Green PJ, Pasternak S. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab. J Cutan Pathol. 2012;39(2):289-293.
33. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol. 2007;26(11):1969-1971. (Pubitemid 47516989)
34. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax. 1996;51(3):238-247.
35. Baughman RP, Judson MA, Teirstein A, et al. Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM. 2006;99(5):307-315.
36. Benali S, Boustière C, Castellani P, et al. Sarcoidosis following pegylated interferon therapy: two cases [in French]. Gastroenterol Clin Biol. 2006;30(4):615-619. (Pubitemid 43844289)
37. Sweiss NJ, Zhang W, Franek BS, et al. Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoido sis manifestations and ancestry. PLoS ONE. 2011;6(12):e29126.
38. Katchar K, Söderström K, Wahlstrom J, Eklund A, Grunewald J. Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J. 2005;26(1):77-85. (Pubitemid 40945934)
39. López V, Molina I, Monteagudo C, Jordá E. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature. Int J Dermatol. 2011;50(3):287-291.
40. Haramati LB, Lee G, Singh A, Molina PL, White CS. Newly diagnosed pulmonary sarcoidosis in HIV-infected patients. Radiology. 2001;218(1):242-246. (Pubitemid 32151302)
41. Naccache JM, Antoine M, Wislez M, et al. Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med. 1999;159(6):2009-2013. (Pubitemid 29275077)
42. Gomez V, Smith PR, Burack J, Daley R, Rosa U. Sarcoidosis after antiretroviral therapy in a patient with acquired immunodeficiency syndrome. Clin Infect Dis. 2000;31(5):1278-1280. (Pubitemid 32295462)
43. Wittram C, Fogg J, Farber H. Immune restoration syndrome manifested by pulmonary sarcoidosis. AJR Am J Roentgenol. 2001;177(6):1427.
44. Trevenzoli M, Cattelan AM, Marino F, Marchioro U, Cadrobbi P. Sarcoidosis and HIV infection: a case report and a review of the literature. Postgrad Med J. 2003;79(935):535-538. (Pubitemid 37193893)
45. Foulon G, Wislez M, Naccache JM, et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis. 2004;38(3):418-425. (Pubitemid 38200122)
46. Ottenhoff TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today. 1998;19(11):491-494. (Pubitemid 28518024)
47. Martel S, Carré PC, Carrera G, Pipy B, Léophonte PJ; Toulouse Lung Transplantation Group. Tumour necrosis factor-alpha gene expression by alveolar macrophages in human lung allograft recipient with recurrence of sarcoidosis. Eur Respir J. 1996;9(5):1087-1089. (Pubitemid 26191656)
48. Ionescu DN, Hunt JL, Lomago D, Yousem SA. Recurrent sarcoidosis in lung transplant allografts: granulomas are of recipient origin. Diagn Mol Pathol. 2005;14(3):140-145. (Pubitemid 41391795)
49. Milman N, Andersen CB, Burton CM, Iversen M. Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells. Eur Respir J. 2005;26(3):549-552. (Pubitemid 41264219)
50. Baughman RP, Drent M, Kavuru M, et al Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174(7):795-802. (Pubitemid 44511661)
51. Judson MA, Baughman RP, Costabel U, et al;Centocor T48 Sarcoidosis Investigators. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31(6):1189-1196.
52. Utz JP, Limper AH, Kalra S, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003;124(1):177-185. (Pubitemid 36851350)
53. O'Shea FD, Marras TK, Inman RD. Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Rheum. 2006;55(6):978-981. (Pubitemid 44917474)
54. Judson MA. The treatment of pulmonary sarcoidosis. Respir Med. 2012;106(10):1351-1361.
55. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153-2165.
56. Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med. 2008;29(3):379-390. (Pubitemid 351778215)
57. Chen ES, Song Z, Willett MH, et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med. 2010;181(4):360-373.
58. Paramothayan NS, Lasserson TJ, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev. 2005; (2):CD001114.
59. Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2011;183(5):573-581.
60. Panselinas E, Rodgers JK, Judson MA. Clinical outcomes in sarcoidosis after cessation of infliximab treatment. Respirology. 2009;14(4):522-528.
61. Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial biopsy for sarcoidosis: a prospective study. Chest. 2001;120(1):109-114. (Pubitemid 32744865)
62. Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis. Chest. 2001;120(3):881-886. (Pubitemid 32885464)
63. Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Müller-Quernheim J. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med. 2008;177(3):330-336. (Pubitemid 351198377)
64. Nishino M, Lee KS, Itoh H, Hatabu H. The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. Eur J Radiol. 2010;73(1):66-73.
65. Oberstein A, von Zitzewitz H, Schweden F, Müller-Quernheim J. Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14(1):65-72. (Pubitemid 27170557)
66. 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay. J Comput Assist Tomogr. 1998;22(2):229-234.
67. Criado E, Sánchez M, Ramírez J, et al. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics. 2010;30(6):1567-1586.
68. Hamper UM, Fishman EK, Khouri NF, Johns CJ, Wang KP, Siegelman SS. Typical and atypical CT manifestations of pulmonary sarcoidosis. J Comput Assist Tomogr. 1986;10(6):928-936. (Pubitemid 17200088)
69. Müller NL, Kullnig P, Miller RR. The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol. 1989;152(6):1179- 1182. (Pubitemid 19140945)
70. Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169(22):2078-2086.
71. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149-173.
72. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest. 2006;129(1):174-181. (Pubitemid 43265259)
73. Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci. 1990;299(3):153-157. (Pubitemid 20085232)
74. Baltzan M, Mehta S, Kirkham TH, Cosio MG. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med. 1999;160(1):192-197. (Pubitemid 29326087)
75. Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med. 1997;155(5):1665-1669. (Pubitemid 27216674)
76. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;155(8):846-851.
77. Johns CJ, Michele TM. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore). 1999;78(2):65-111. (Pubitemid 29153026)